Loading clinical trials...
Loading clinical trials...
A Single Center, Randomized, Subject and Evaluator Blinded, Split-face, Pivotal Clinical Trial to Evaluate the Efficacy and Safety of DKB-119 in Crow's Feet
To prove the non-inferiority of DKB-119 by evaluating the injecting efficacy and safety DKB-119 and control for patients in crow's feet
A single center, randomized, subject and evaluator blinded, split-face, pivotal clinical trial
Age
19 - 70 years
Sex
ALL
Healthy Volunteers
No
Chungang-University Hospital
Seoul, South Korea
Start Date
November 2, 2020
Primary Completion Date
September 8, 2023
Completion Date
October 31, 2023
Last Updated
September 13, 2023
100
ACTUAL participants
DKB-119
DEVICE
Lead Sponsor
Dongkook Pharmaceutical Co., Ltd.
NCT04818203
NCT04985916
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06402058